Lummis Asset Management, LP
Source: SEC Form 13F · as of Mar 2026Lummis Asset Management, LP holds 14 biotech & pharma companies tracked by BioSniper, totaling $11.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$11.3M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 12,873 | $3.0M |
| ABTABBOTT LABORATORIES | 29,488 | $2.9M |
| LLYELI LILLY & Co | 2,674 | $2.5M |
| ABBVAbbVie Inc. | 6,229 | $1.3M |
| AMGNAMGEN INC | 3,433 | $1.2M |
| PFEPFIZER INC | 11,314 | $302K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 249 | $67K |
| IDXXIDEXX LABORATORIES INC /DE | 35 | $20K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 29 | $13K |
| ZTSZoetis Inc. | 40 | $5K |
| SNYSanofi | 80 | $4K |
| PMPhilip Morris International Inc | 23 | $4K |
| NVSNovartis AG | 16 | $2K |
| GEHCGE HealthCare Technologies Inc. | 4 | $285 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.